Patten B M
Acta Neurol Scand. 1984 Jul;70(1):47-61. doi: 10.1111/j.1600-0404.1984.tb00802.x.
Increasing numbers of patients are being recognized with neurological abnormalities associated with the immunochemical changes of plasma cell disease. To illustrate the wide spectrum of clinical disorders that can be found, I discuss in detail 5 patients: 2 with neuropathy, 3 with amyotrophic lateral sclerosis (ALS), all of whom had serum monoclonal paraproteinemia. In addition, I report in tabular form 6 patients with paraproteinemia and the following clinical presentations: 1) systemic lupus with polyneuropathy and severe cerebritis, 2) myasthenia gravis with thymoma, 3) polymyositis, 4) polymyositis, arthritis and Grave's disease, 5) relapsing polyneuritis (one of the original patients diagnosed by Austin) and 6) ALS, dystonia and parkinsonism. Major improvements in clinical condition occurred sometimes, but not always, coincident with reductions in the levels of the paraprotein using prednisone, cyclophosphamide, chlorambucil and plasma exchange treatments even in some of the patients who had the clinical appearance of ALS. Patients with neuromuscular diseases should be routinely screened with serum immunoelectrophoresis for monoclonal gammopathy. If a monoclonal gammopathy is found and if the disease is serious, then those patients should be treated as if they had an autoimmune disorder.
越来越多的患者被发现存在与浆细胞疾病免疫化学变化相关的神经异常。为了说明可能出现的广泛临床病症,我详细讨论了5例患者:2例患有神经病变,3例患有肌萎缩侧索硬化症(ALS),他们均患有血清单克隆副蛋白血症。此外,我以表格形式报告了6例患有副蛋白血症及以下临床表现的患者:1)伴有多发性神经病变和严重脑炎的系统性红斑狼疮,2)伴有胸腺瘤的重症肌无力,3)多发性肌炎,4)多发性肌炎、关节炎和格雷夫斯病,5)复发性多发性神经炎(最初由奥斯汀诊断的患者之一),以及6)ALS、肌张力障碍和帕金森症。临床状况有时会有显著改善,但并非总是如此,即使在一些有ALS临床表现的患者中,使用泼尼松、环磷酰胺、苯丁酸氮芥和血浆置换治疗后,副蛋白水平降低时也会出现这种情况。患有神经肌肉疾病的患者应常规进行血清免疫电泳筛查单克隆丙种球蛋白病。如果发现单克隆丙种球蛋白病且病情严重,那么这些患者应按照患有自身免疫性疾病进行治疗。